SHANGHAI, China, July 19, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated ...
SHANGHAI, June 18, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
Loqtorzi combined with chemotherapy significantly improved PFS and OS in ES-SCLC patients, offering a new first-line treatment option. The EXTENTORCH study showed a 33% reduction in disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results